|
2D-DIGE
|
Two dimensional –
differential gel electrophoresis |
|
AA |
Black or African
American |
|
AA |
African American |
|
ACN |
Acetonitrile |
|
ADT |
Androgen
deprivation therapy |
|
ALT |
Alanine
transaminase |
|
ANOVA |
Analysis of
Variance |
|
AR |
Androgen receptor
|
|
ASCs |
Adipocyte stromal
cells |
|
AST |
Aspartate
aminotransferase |
|
BER |
Base excision
repair |
|
BLI |
Bioluminescent
imaging |
|
CA |
Caucasian |
|
CAN |
Copy number
alteration |
|
CART |
Classification
and regression tree |
|
CK |
Creatine kinase
|
|
CK5, -8 CK8 |
Cytokeratin-5
|
|
CNV |
Copy number
variant |
|
cPten-/-L |
Conditional
probasin-luciferase expression |
|
CTL |
Cytotoxic T cell lymphocytes |
|
DIGE |
Differential gel
electrophoresis |
|
DMEM |
Dulbecco's
Modified Eagle Medium |
|
DNA |
Deoxyribonucleic
acid |
|
DTT |
Dithiothritol |
|
EA |
Caucasian or
European American |
|
EGFR |
Epidermal growth
factor receptor |
|
EPR |
Enhance
permeability and retention |
|
ESI-QTOF
|
Electrospray
ionization -quadrupole time-of-flight mass spectrometry |
|
EZH2 |
Enhancer of zeste homolog 2 |
|
FACS |
Fluorescence-activated cell sorter |
|
FBS |
Fetal bovine
serum |
|
FDA |
Food and Drug Administration |
|
FDR |
False Discovery
Rate |
|
FFPE |
Formalin-fixed,
paraffin-embedded |
|
FRá/FR1, - FRâ/FR2,
- FRã/FR3, and -FRä/FR4 |
Folate receptors |
|
gIFN |
Interferon Gamma |
|
GnRH |
Gonadotropin-releasing
hormone |
|
GU |
Georgetown
University |
|
HRP |
Horseradish peroxidase |
|
IFN |
Interferon
|
|
IHC |
Immunohistochemistry |
|
IHC |
Immunohistochemistry |
|
II dichloride (cisplatin) |
cis-diammineplatinum |
|
IL |
Interleukin
|
|
IL-4 |
Interleukin 4 |
|
IL-8 |
Interleukin 8 |
|
IL-10 |
Interleukin 10 |
|
IL-12 |
Interleukin 12 |
|
IL-13 |
Interleukin 13 |
|
IL-23 |
Interleukin 23 |
|
IRF1 |
Interferon Regulatory Factor-1 |
|
IHC |
Immunohistochemistry |
|
IF |
Immunofluorescence |
|
iNOS |
Inducible nitric oxide synthase |
|
IRB |
International
review board |
|
iTRAQ
|
Isobaric tag for
relative and absolute quantitation |
|
IVIS |
in vivo
imaging system |
|
KCNB2
|
Potassium
voltage-gated channel subfamily B member 2 |
|
KCNMA1
|
Potassium large
conductance calcium-activated channel, subfamily M, alpha |
|
KCNQ3
|
Potassium
voltage-gated channel, KQT-like subfamily, member 3 |
|
K-SFM |
Keratinocyte
serum free medium |
|
LARS |
Least angle
regression |
|
LC |
Liquid
chromatography |
|
LC/MS
|
Liquid
chromatography mass spectrometry |
|
LC/MS/MS
|
Liquid
chromatography tandem mass spectrometry |
|
LCCC |
Lombardi
Comprehensive Cancer Center |
|
m/z |
Mass to charge
ratio |
|
MANOVA |
Multivariate
Analysis of Variance |
|
MDA |
Multivariate data
analysis |
|
MDOR |
Minimum
detectable odds ratios |
|
MDS |
Multi-dimensional
scaling |
|
MDSC |
Myeloid derived suppressor cells |
|
METS |
Metastases |
|
MMP7 |
Matix metalloprotein 7 |
|
MMP9 |
Matix metalloprotein 9 |
|
MMR |
Mutations DNA
mismatch repair |
|
MRM |
Multiple reaction
monitoring |
|
MS |
Mass spectrometry |
|
MS/MS
|
Tandem mass
spectrometry |
|
MYC |
Avian
myelocytomatosis viral oncogene homolog |
|
NanoUPLC
|
Nanoflow ultra
performance liquid chromatography |
|
NanoUPLC-QTOFLCMS/MS
|
Nanoflow ultra
performance liquid chromatography, |
|
NER |
Nucleotide
excision repair |
|
NIH |
National
Institute of Health,
USA |
|
NK |
Natural killer cells |
|
NFkB |
Nuclear Factor Kappa B |
|
NGS |
Next Generation Sequencing |
|
NMR |
Nuclear magnetic
resonance |
|
OPLS-DA
|
Orthogonal
partial least square discriminant analysis. |
|
OR |
Odds ratio |
|
PAR |
Population
attributable risk |
|
PC |
Prostate cancer |
|
PCa |
Prostate cancer
|
|
PCA |
Principal
components analysis |
|
PCR |
Polymerase chain
reaction (variations on prefix) |
|
PDAC |
Pancreatic ductal
adenocarcinoma |
|
PGA |
Power for Genetic
Association Analysis |
|
PI |
Principal
investigator |
|
PIN |
prostatic
intraepithelial neoplasia |
|
PLS-DA
|
Projections to
latent structures directed analysis |
|
PMSR |
Proteomics and
Metabolomics Shared Resource |
|
Power |
Statistical
measure of confidence |
|
PPA |
Proteomic Pathway
Array |
|
PSA |
Prostate-specific
antigen |
|
PTEN tumor
suppressor gene |
Phosphatase and
tensin homolog deleted on chromosome 10 |
|
QTOF/MS |
Quadrupole- time
of flight tandem mass spectrometry |
|
RES |
Reticuloendothelial system |
|
RF |
Random Forest (a
statistical programming language) |
|
RFC |
Reduced folate
carrier |
|
ROC |
Receiver operator
curve |
|
RPMI |
Roswell Park
Memorial Institute |
|
SAM |
Significant
Analysis of Microarray |
|
SCID |
Severe Combined
Immunodeficiency |
|
SCX |
Strong cation
exchange chromatography |
|
SD |
Standard
deviation |
|
SEM |
Standard Error of
Means |
|
SIMCA
|
Soft independent
modeling of class analogy |
|
SPINK1
|
Serine protease
inhibitor kazal type 1 gene has recently been implicated in the
biology of PCa. This study being conducted at National Human Genome |
|
TAM |
Tumor-associated
macrophages |
|
TGF |
Transforming
growth factor |
|
TGFb
|
Tumor growth
factor-Beta(1) |
|
Th17 - type 17 |
T helper type 17
|
|
Th1 |
T helper cell, class 1. |
|
Th2 |
T helper cell,
class 2 |
|
TMA |
Tissue microarray |
|
TMN |
Tumor,
metastases, nodes |
|
TNF |
Tumor necrosis
factor |
|
TRAIL |
TNF related
apoptosis inducing factor |
|
TRAMP |
Transgenic
adenocarcinoma mouse prostate |
|
Treg |
T regulatory
|
|
UPLC-TOFMS
|
Ultra performance
Liquid Chromatography time-of-flight mass spectrometry (a form of
LC-MS) |
|
WA |
White American |
|
XPclad
nanoparticles |
Clad
nanoparticles |
|
|
|
|
PC or PDC |
Partition
distribution coefficient or partition coefficient is the ratio of
concentrations of a compound in the two phases of a mixture of two
immiscible solvents (e.g., water~hydrophilic and at equilibrium and
octanol~hydrophobic) to predict the distribution of drugs (logP) |
|
|
|
|
|
|
